Research by Nicholas Moroz

(Displaying 1 to 5 of 5)
This briefing presents the findings of a survey conducted with 620 individuals in Canada using the Occupational Stress Injury Resiliency (OSIR) Index screening tool for first responders...
The Conference Board of Canada | 24 pages | February 2021 | by Bill Howatt, Nicholas Moroz
Workplace Safety & Prevention Services and The Conference Board of Canada developed a Mental Harm Prevention Roadmap. The Roadmap facilitates the creation of mental health strategies...
The Conference Board of Canada | 32 pages | December 2020 | by Bill Howatt, Andrew Harkness, Andrew Tomayer, Nicholas Moroz, Charles Boyer
Disease-modifying therapies (DMTs) slow down brain lesions and ease relapses in multiple sclerosis patients—but why can’t Canadians easily access them? This primer examines DMTs’...
The Conference Board of Canada | 48 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
Les immunomodulateurs ralentissent les lésions au cerveau et diminuent la fréquence des poussées chez les patients atteints de la sclérose en plaques. Alors, pourquoi les Canadiens...
Le Conference Board du Canada | 53 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
Will Canada be able to keep up with Canada’s growing eye needs? This impact paper quantifies the value of ophthalmology from a population health, health care system, and broader...
The Conference Board of Canada | 37 pages | November 2020 | by Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo, Zhenzhen Ye
(Displaying 1 to 5 of 5)